IPO hopeful Distinct Healthcare targets the well-to-do market
The private healthcare provider is hoping to attract investors with a business model focusing on the medical needs of affluent families in leading Chinese cities Key Takeaways: The company has…
FAST NEWS: Fosun Pharma’s Revenue Growth Slows Sharply in Third Quarter
The latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) said Sunday its revenue increased 1.7% year-on-year to 10.27 billion yuan ($1.4 billion) in the third quarter, as measured using…
FAST NEWS: Fosun Pharma Spends $160 Million on Singapore Cancer Clinic
The latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) announced Monday evening it will acquire a 60% stake in Oncocare Medical Pte Ltd, one of the local largest private medical…
